Tasuku Hara Selected Research

Hypertension (High Blood Pressure)

8/2019	HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
3/2014	Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tasuku Hara Research Topics

Disease

12	Non-alcoholic Fatty Liver Disease 08/2020 - 09/2010
9	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 09/2013
8	Infections 08/2021 - 10/2013
8	Fibrosis (Cirrhosis) 01/2020 - 09/2010
6	Chronic Hepatitis C 08/2021 - 05/2011
5	Body Weight (Weight, Body) 01/2019 - 09/2013
4	Neoplasms (Cancer) 03/2020 - 09/2013
4	Alcoholic Fatty Liver 02/2018 - 09/2010
4	Insulin Resistance 02/2018 - 09/2010
3	Inflammation (Inflammations) 01/2019 - 07/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 10/2017 - 03/2014
3	Chronic Hepatitis B 12/2015 - 03/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 07/2021 - 10/2020
2	Hypertension (High Blood Pressure) 08/2019 - 03/2014
2	Obesity 01/2019 - 09/2015
2	Glucose Intolerance 02/2018 - 05/2011
2	Type 2 Diabetes Mellitus (MODY) 10/2017 - 09/2017
2	Hepatitis 10/2015 - 01/2014
2	Anemia 10/2014 - 10/2013
1	Lymphatic Metastasis 08/2023
1	Duodenal Neoplasms (Duodenal Cancer) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Cachexia 01/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023
1	Pancreatitis 01/2023
1	Cholangitis 03/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Adenocarcinoma 01/2022
1	Lymphoma (Lymphomas) 02/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2021
1	Residual Neoplasm 05/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Dyslipidemias (Dyslipidemia) 08/2019
1	Portal Hypertension 04/2019
1	Atherosclerosis 01/2019
1	Gastritis 01/2019
1	Exanthema (Rash) 10/2015
1	Chemical and Drug Induced Liver Injury 10/2015

Drug/Important Bio-Agent (IBA)

6	Transaminases (Aminotransferases)IBA 02/2019 - 05/2011
4	Glucose (Dextrose)FDA LinkGeneric 08/2019 - 05/2011
4	telaprevirIBA 10/2015 - 10/2013
3	Proteins (Proteins, Gene)FDA Link 08/2020 - 05/2011
3	Amino Acids FDA Link 01/2014 - 05/2011
2	lenvatinibIBA 03/2020 - 09/2019
2	InterferonsIBA 01/2020 - 10/2015
2	Insulin (Novolin)FDA Link 08/2019 - 07/2015
2	Hemoglobins (Hemoglobin)IBA 10/2017 - 09/2017
2	Alanine Transaminase (SGPT)IBA 07/2017 - 10/2015
2	nasIBA 10/2015 - 09/2015
2	Ribavirin (Virazole)FDA LinkGeneric 10/2015 - 10/2013
2	Lamivudine (Epivir)FDA Link 06/2014 - 03/2014
2	lipoarabinomannan (LAM)IBA 06/2014 - 03/2014
2	adefovir dipivoxil (Hepsera)FDA Link 06/2014 - 03/2014
1	Capecitabine (Xeloda)FDA Link 08/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2023
1	anamorelinIBA 01/2023
1	Ghrelin ReceptorsIBA 01/2023
1	Diclofenac (SR 38)FDA LinkGeneric 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2022
1	Gemcitabine FDA Link 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	glecaprevirIBA 08/2021
1	pibrentasvirIBA 08/2021
1	Rituximab (Mabthera)FDA Link 02/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	acarboxyprothrombin (PIVKA)IBA 08/2020
1	lentil lectinIBA 08/2020
1	Vitamin K FDA Link 08/2020
1	CytokinesIBA 01/2019
1	AdipokinesIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	EnzymesIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Serum AlbuminIBA 03/2018
1	Therapeutic UsesIBA 01/2018
1	Messenger RNA (mRNA)IBA 12/2017
1	InterleukinsIBA 12/2017
1	NucleotidesIBA 12/2017
1	adiponutrinIBA 12/2017
1	Caspase 1 (ICE Protease)IBA 12/2017
1	Interleukin-18 (Interleukin 18)IBA 12/2017
1	InflammasomesIBA 12/2017
1	dulaglutideIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Phospholipases (Phospholipase)IBA 10/2017
1	Glucagon (Glukagon)FDA Link 10/2017
1	Sodium-Glucose Transport ProteinsIBA 09/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2017
1	Collagen Type IV (Type IV Collagen)IBA 07/2017
1	peginterferon alfa-2a (Pegasys)FDA Link 12/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2015

Therapy/Procedure

15	Therapeutics 01/2022 - 09/2013
6	Drug Therapy (Chemotherapy) 08/2023 - 09/2013
1	Rectal Administration 01/2023
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2021
1	Liver Transplantation 08/2020
1	Oral Hygiene (Dental Hygiene) 01/2019